Delivery Order SPE2D021DA002-SPE2D324F174J

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a medication used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a type of pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,605.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract, which has no set-aside designation, is for the provision of procainamide hydrochloride injection USP, a medication primarily used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant indefinite delivery...
This federal contract award, valued at $1,605.15, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Procainamide Hydrochloride Injection USP, a pharmaceutical product, to support the medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,277.81 contract is for the delivery of Procainamide Hydrochloride, a pharmaceutical product, with a completion date of December 13, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,155.02, is for the delivery of Procainamide 1 gram/10 ml vial (10 ml) to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group...
This is a $1,265.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product Procainamide 1,000 mg/10 ml syringe, 10 ml. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,210.30 award is for the supply of procainamide hydrochloride injection USP, a medication used to treat certain heart rhythm disorders. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a $1,605.15 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, issued under the DLA's SPE2DB program, is for the delivery of Procainamide Hydrochloride Injection USP, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is not associated with a...
This federal contract award, with ID SPE2D021DA002|SPE2D325F1756, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,210.30 firm fixed-price delivery order is for the provision of Procainamide Hydrochloride Injection USP, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F174J
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,605.15, is for the provision of Procainamide Hydrochloride Injection USP to support the recurring medical supply needs of military health facilities worldwide.

DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both routine and critical medications, to fulfill the diverse medical requirements of Department of Defense (DoD) healthcare facilities globally. The current delivery order is not set-aside and is part of this larger IDC contract vehicle.

Generated 11/1/24, 9:20 AM